Drug Shortage Report for MYLAN-NIFEDIPINE EXTENDED RELEASE
Report ID | 104685 |
Drug Identification Number | 02321149 |
Brand name | MYLAN-NIFEDIPINE EXTENDED RELEASE |
Common or Proper name | NIFEDIPINE |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | NIFEDIPINE |
Strength(s) | 60MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 100BT |
ATC code | C08CA |
ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF. |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2020-01-20 |
Estimated end date | 2020-07-07 |
Actual end date | 2020-06-09 |
Shortage status | Resolved |
Updated date | 2020-06-10 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2020-01-29 | French | Compare |
v1 | 2020-01-29 | English | Compare |